NXTM:NAS (USA) Also trade in: Germany

NxStage Medical Inc

$ 30 0 (0%)
Volume: 0 Avg Vol (1m): 6,195,319
Market Cap $: 2.00 Bil Enterprise Value $: 1.93 Bil
P/E (TTM): 0.00 P/B: 8.88
Earnings Power Value 2.57
Net Current Asset Value 0.88
Tangible Book 2.65
Projected FCF 0.62
Median P/S Value 23.4
Graham Number 0
Peter Lynch Value -2
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 7/10

Current vs industry vs history
Cash-to-Debt 6.16
Equity-to-Asset 0.60
Debt-to-Equity 0.06
Debt-to-EBITDA 0.43
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.93
DISTRESS
GREY
SAFE
Beneish M-Score -1.92
Not Manipulator
Manipulator

Profitability & Growth : 6/10

Current vs industry vs history
Operating Margin % -0.65
Net Margin % -1.28
ROE % -2.52
ROA % -1.60
ROC (Joel Greenblatt) % -2.07
3-Year Total Revenue Growth Rate 9.30
3-Year Total EBITDA Growth Rate 53.50
3-Year EPS w/o NRI Growth Rate 17.40

» NXTM's 30-Y Financials

Financials (Next Earnings Date: 2019-05-09)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:NXTM

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS : 334510    SIC : 3845
Compare SZSE:002414 FRA:PHH2 TSE:7732 NAS:IRTC NYSE:HYH SZSE:300595 TSE:7730 TSE:3593 ROCO:1565 SZSE:300061 NAS:ATRI NAS:MMSI NYSE:GKOS NAS:NVCR NAS:OSUR XMCE:FAE XKLS:7153 SZSE:002901 NAS:LMNX XTER:GXI
Traded in other countries N5X.Germany
Address
NxStage Medical develops and manufactures products and services for patients with chronic or acute kidney failure. The firm operates in three segments: System One, In-Center, and Services. The System One segment contributes the majority of revenue. It sells and rents the System One portable hemodialysis systems and related consumable products for home and critical care hemodialysis treatments. The In-Center segment sells blood tubing sets and needles for hemodialysis, primarily to dialysis clinics. This business has a high degree of customer concentration. The Services business provides dialysis to customers at NxStage Kidney Care dialysis centers. NxStage generates the majority of its revenue in the United States.

Ratios

Current vs industry vs history
Price-to-Owner-Earnings 1578.95
PB Ratio 8.88
PS Ratio 4.68
Price-to-Free-Cash-Flow 114.50
Price-to-Operating-Cash-Flow 84.99
EV-to-EBIT -693.09
EV-to-EBITDA 61.78
EV-to-Revenue 4.54
Current Ratio 3.60
Quick Ratio 2.69
Days Inventory 77.12
Days Sales Outstanding 56.66
Days Payable 29.88

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -1.90

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 11.32
Price-to-Projected-FCF 48.39
Price-to-Median-PS-Value 1.28
Earnings Yield (Joel Greenblatt) % -0.14
Forward Rate of Return (Yacktman) % 19.53

More Statistics

Revenue (TTM) (Mil) $ 425.99
EPS (TTM) $ -0.08
Beta 0
Volatility % 12.84
52-Week Range $ 23.17 - 30
Shares Outstanding (Mil) 66.29

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA N
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y